As 2025 comes to a close, Ophthalmology 360 is taking a look back at the most popular videos published this year.
1. When to remove sutures after pediatric cataract surgery?
Parul Chawla Gupta, MS, MBBS, shared the most optimal time to remove sutures after surgery in pediatric patients with cataracts.
2. Study assesses outcomes and offers management recommendations for the treatment of cataracts in pediatric patients with developmental delays
At the American Association for Pediatric Ophthalmology and Strabismus Annual Meeting, Yoav Glidai, MD, discussed the challenges associated with the surgical management of cataracts in patients with developmental delays.
3. IRIS Registry data shows early aflibercept 8 mg use allows for 12-week injection intervals in AMD and DME cohorts
Diana Do, MD, spoke about a study that used IRIS Registry data to determine whether use of aflibercept 8 mg at the beginning of treatment for AMD or DME could improve outcomes and interval dosing.
4. AI’s potential for early diagnosis of vitreoretinal lymphoma
Ogul Uner, MD, presented a study at AAO 2025 that used artificial intelligence to assess OCT scans and determine whether patients had vitreoretinal lymphoma.
5. Is My Practice Interventional? The Importance of a Practice Assessment
This year, Ophthalmology 360 debuted The Interventional Glaucoma Project, a series dedicated to showcasing outcomes from real-world glaucoma-focused practices that underwent internal assessments to determine how interventional their approach to care was. In episode 1, Mark Gallardo, MD, found that he was not as interventional as he had thought.
Don’t forget the top podcasts
1. First-line Therapies for Glaucoma: Topical Drops vs. Procedures
Christine Funke, MD, Brian Shafer, MD, and J. Morgan Micheletti, MD, talk about optimal first-line treatment for glaucoma and how to introduce a more interventional approach.
2. Test corneal sensation to identify this lesser-known ocular condition
In an episode of The Spotlight Series Podcast, host Mario Nacinovich speaks with John Sheppard, MD, about neurotrophic keratitis, a lesser-known condition that requires swift clinician awareness, diagnosis, and referral and/or treatment. They also discuss a “revolutionary” drug to treat this condition.
Related Content
